| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698257 | Clinical Oncology | 2016 | 6 Pages |
Abstract
SBRT for oligometastatic PCa nodal recurrences is safe. Most subsequent relapses are again nodal and oligometastatic.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
P. Ost, B.A. Jereczek-Fossa, N. Van As, T. Zilli, A. Tree, D. Henderson, R. Orecchia, F. Casamassima, A. Surgo, R. Miralbell, G. De Meerleer,